{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:43:21Z","timestamp":1768319001841,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01 HD077108"],"award-info":[{"award-number":["NIH R01 HD077108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571510"],"award-info":[{"award-number":["81571510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12958-019-0469-8","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:50Z","timestamp":1550844290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-8810","authenticated-orcid":false,"given":"Liping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoqin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsey","family":"Baiamonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moselle","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mistie","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erma Z.","family":"Drobnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Quayle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny J.","family":"Schust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"469_CR1","volume-title":"Global AIDS Update","author":"UNAIDS","year":"2016","unstructured":"UNAIDS. Global AIDS Update. Geneva: Joint United Nations Programme on HIV\/AIDS; 2016."},{"key":"469_CR2","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1086\/651483","volume":"50","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Sibeko S, Baxter C. Preventing HIV infection in women: a global health imperative. Clin Infect Dis. 2010;50:S122\u20139.","journal-title":"Clin Infect Dis"},{"key":"469_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bpobgyn.2008.11.007","volume":"23","author":"I Mavranezouli","year":"2009","unstructured":"Mavranezouli I. Health economics of contraception. Best Pract Res Clin Obstet Gynaecol. 2009;23:187\u201398.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"469_CR4","doi-asserted-by":"publisher","first-page":"ii54","DOI":"10.1136\/sti.2008.030098","volume":"84","author":"R Wilcher","year":"2008","unstructured":"Wilcher R, Petruney T, Reynolds HW, Cates W. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect. 2008;84:ii54\u201360.","journal-title":"Sex Transm Infect"},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/01.olq.0000194602.01058.e1","volume":"33","author":"HW Reynolds","year":"2006","unstructured":"Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis. 2006;33:350\u20136.","journal-title":"Sex Transm Dis"},{"key":"469_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/01.aids.0000131353.06784.8f","volume":"18","author":"MD Sweat","year":"2004","unstructured":"Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS. 2004;18:1661\u201371.","journal-title":"AIDS."},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1086\/519432","volume":"45","author":"JM Baeten","year":"2007","unstructured":"Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis. 2007;45:360\u20139.","journal-title":"Clin Infect Dis"},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"e96497","DOI":"10.1371\/journal.pone.0096497","volume":"9","author":"Y Govender","year":"2014","unstructured":"Govender Y, Avenant C, Verhoog NJ, Ray RM, Grantham NJ, Africander D, et al. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. PLoS One. 2014;9:e96497.","journal-title":"PLoS One"},{"key":"469_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1089\/aid.2012.0271","volume":"29","author":"N Chandra","year":"2013","unstructured":"Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retrovir. 2013;29:592\u2013601.","journal-title":"AIDS Res Hum Retrovir"},{"key":"469_CR10","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2014.05.016","volume":"211","author":"SL Achilles","year":"2014","unstructured":"Achilles SL, Creinin MD, Stoner KA, Chen BA, Meyn L, Hillier SL. Changes in genital tract immune cell populations after initiation of intrauterine contraception. Am J Obstet Gynecol. 2014;211:489.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"469_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/infdis\/jiv233","volume":"212","author":"G Sciaranghella","year":"2015","unstructured":"Sciaranghella G, Wang C, Hu H, Anastos K, Merhi Z, Nowicki M, et al. CCR5 expression levels in HIV-uninfected women receiving hormonal contraception. J Infect Dis. 2015;212:1397\u2013401.","journal-title":"J Infect Dis"},{"key":"469_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","volume":"16","author":"EH Byrne","year":"2016","unstructured":"Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, et al. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in south African women: a prospective cohort study. Lancet Infect Dis. 2016;16:441\u20138.","journal-title":"Lancet Infect Dis"},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(14)71052-7","volume":"15","author":"LJ Ralph","year":"2015","unstructured":"Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis. 2015;15:181\u20139.","journal-title":"Lancet Infect Dis"},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1097\/QAD.0b013e32833a2537","volume":"24","author":"CS Morrison","year":"2010","unstructured":"Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS. 2010;24:1778\u201381.","journal-title":"AIDS."},{"key":"469_CR15","doi-asserted-by":"publisher","first-page":"e1001778","DOI":"10.1371\/journal.pmed.1001778","volume":"12","author":"CS Morrison","year":"2015","unstructured":"Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12:e1001778.","journal-title":"PLoS Med"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","volume":"12","author":"R Heffron","year":"2012","unstructured":"Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analysis. Lancet Infect Dis. 2012;12:19\u201326.","journal-title":"Lancet Infect Dis"},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/515654","volume":"178","author":"HL Martin Jr","year":"1998","unstructured":"Martin HL Jr, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998;178:1053\u20139.","journal-title":"J Infect Dis"},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/humrep\/deu113","volume":"29","author":"AM Crook","year":"2014","unstructured":"Crook AM, Ford D, Gafos M, Hayes R, Kamali A, Kapiga S, et al. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod. 2014;29:1810\u20137.","journal-title":"Hum Reprod"},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","volume":"197","author":"EM Stringer","year":"2007","unstructured":"Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"469_CR20","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/01.aids.0000363779.65827.e0","volume":"23","author":"EM Stringer","year":"2009","unstructured":"Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS, et al. Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-plus initiative. AIDS. 2009;23:S69\u201377.","journal-title":"AIDS."},{"key":"469_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/QAD.0b013e32835ad473","volume":"27","author":"R Heffron","year":"2013","unstructured":"Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, et al. Hormonal contraceptive use and risk of HIV-1 disease progression. AIDS. 2013;27:261\u20137.","journal-title":"AIDS."},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/QAD.0b013e32834fa13d","volume":"26","author":"CS Morrison","year":"2012","unstructured":"Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS. 2012;26:497\u2013504.","journal-title":"AIDS."},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.contraception.2015.02.004","volume":"91","author":"KM Wall","year":"2015","unstructured":"Wall KM, Kilembe W, Vwalika B, Htee Khu N, Brill I, Chomba E, et al. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012. Contraception. 2015;91:480\u20137.","journal-title":"Contraception."},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1001\/jama.1993.03500220046024","volume":"269","author":"DB Clemetson","year":"1993","unstructured":"Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993;269:2860\u20134.","journal-title":"JAMA."},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","volume":"25","author":"NR Mugo","year":"2011","unstructured":"Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1 serodiscordant couples. AIDS. 2011;25:1887\u201395.","journal-title":"AIDS."},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","volume":"272","author":"G Alkhatib","year":"1996","unstructured":"Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955\u20138.","journal-title":"Science."},{"key":"469_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/381661a0","volume":"381","author":"H Deng","year":"1996","unstructured":"Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661\u20136.","journal-title":"Nature."},{"key":"469_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.272.5263.872","volume":"272","author":"Y Feng","year":"1996","unstructured":"Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872\u20137.","journal-title":"Science."},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1600-0897.2008.00639.x","volume":"60","author":"M Ficarra","year":"2008","unstructured":"Ficarra M, Ibana JS, Poretta C, Ma L, Myers L, Taylor SN, et al. A distinct cellular profile is seen in the human endocervix during chlamydia trachomatis infection. Am J Reprod Immunol. 2008;60:415\u201325.","journal-title":"Am J Reprod Immunol"},{"key":"469_CR30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1095\/biolreprod.105.043133","volume":"73","author":"J Pudney","year":"2005","unstructured":"Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod. 2005;73:1253\u201363.","journal-title":"Biol Reprod"},{"key":"469_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0165-0378(01)00114-0","volume":"52","author":"M Prakash","year":"2001","unstructured":"Prakash M, Kapembwa MS, Gotch F, Patterson S. Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J Reprod Immunol. 2001;52:101\u201311.","journal-title":"J Reprod Immunol"},{"key":"469_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2567.2003.01623.x","volume":"109","author":"GR Yeaman","year":"2003","unstructured":"Yeaman GR, Howell AL, Weldon S, Demian DJ, Collins JE, O'Connell DM, et al. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology. 2003;109:137\u201346.","journal-title":"Immunology."},{"key":"469_CR33","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0046-8177(96)90458-X","volume":"27","author":"S Rosini","year":"1996","unstructured":"Rosini S, Caltagirone S, Tallini G, Lattanzio G, Demopoulos R, Piantelli M, et al. Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection. Hum Pathol. 1996;27:834\u20138.","journal-title":"Hum Pathol"},{"key":"469_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","volume":"26","author":"F Hladik","year":"2007","unstructured":"Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26:257\u201370.","journal-title":"Immunity."},{"key":"469_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0952-7915(97)80110-0","volume":"9","author":"JP Moore","year":"1997","unstructured":"Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. Curr Opin Immunol. 1997;9:551\u201362.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"469_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/mi.2016.121","volume":"10","author":"KK Smith-McCune","year":"2017","unstructured":"Smith-McCune KK, Hilton JF, Shanmugasundaram U, Critchfield JW, Greenblatt RM, Seidman D, et al. Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility. Mucosal Immunol. 2017;10(5):1270\u20138.","journal-title":"Mucosal Immunol"},{"key":"469_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1933719108325510","volume":"16","author":"JS Sheffield","year":"2009","unstructured":"Sheffield JS, Wendel GD Jr, McIntire DD, Norgard MV. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci. 2009;16:20\u201331.","journal-title":"Reprod Sci"},{"issue":"13\u20138","key":"469_CR38","first-page":"37","volume":"7","author":"S Killick","year":"2002","unstructured":"Killick S. Complete and robust ovulation inhibition with NuvaRing. Eur J Contracept Reprod Health Care. 2002;7(13\u20138):37\u20139.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"469_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/315776","volume":"182","author":"SM Smith","year":"2000","unstructured":"Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis. 2000;182:708\u201315.","journal-title":"J Infect Dis"},{"key":"469_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1210\/er.2009-0018","volume":"31","author":"Z Hel","year":"2010","unstructured":"Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 2010;31:79\u201397.","journal-title":"Endocr Rev"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-019-0469-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:43:11Z","timestamp":1589528591000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-019-0469-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1186\/s12958-019-0469-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Health Sciences Institutional Review Board of the University of Missouri, Columbia, USA and the Medical Ethics Committee of Guangzhou First People\u2019s Hospital, Guangzhou, China. Informed written consent was obtained from each participant prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}